title: Possible association of anti-tumor necrosis factor-α antibody therapy with the development of scleroderma-like changes with lichen planus.
authors.affiliation: Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
authors.forename: Tomoko
authors.initials: T
authors.lastname: Inoue-Nishimoto
authors.affiliation: Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan., Department of Dermatology, Tokyo Medical and Dental University, Graduate School of Medicine, Yushima 1-5-45, Bunkyo-ku, Tokyo 113-8519, Japan.
authors.forename: Takaaki
authors.initials: T
authors.lastname: Hanafusa
authors.affiliation: Department of Dermatology, Tokyo Medical and Dental University, Graduate School of Medicine, Yushima 1-5-45, Bunkyo-ku, Tokyo 113-8519, Japan.
authors.forename: Ken
authors.initials: K
authors.lastname: Igawa
authors.affiliation: Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Azukizawa
authors.affiliation: Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
authors.forename: Akinori
authors.initials: A
authors.lastname: Yokomi
authors.affiliation: Department of Dermatology, Tokyo Medical and Dental University, Graduate School of Medicine, Yushima 1-5-45, Bunkyo-ku, Tokyo 113-8519, Japan.
authors.forename: Hiroo
authors.initials: H
authors.lastname: Yokozeki
authors.affiliation: Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
authors.forename: Ichiro
authors.initials: I
authors.lastname: Katayama
mesh_terms: D000068879:Adalimumab / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D001707:Biopsy, Needle; D003875:Drug Eruptions / Q000209:etiology / Q000473:pathology; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D008010:Lichen Planus / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D011565:Psoriasis / Q000175:diagnosis / Q000188:drug therapy*; D018570:Risk Assessment; D012594:Scleroderma, Localized / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage / Q000037:antagonists & inhibitors*
chemical_list: D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab